Discontinuation report 3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE
| Report ID | 148651 |
| Drug Identification Number | 00038881 |
| Brand name | 3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE |
| Common or Proper name | Dextrose and Sodium Chloride Injection USP |
| Company Name | ICU MEDICAL CANADA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | SODIUM CHLORIDE DEXTROSE |
| Strength(s) | 3MG 33.3MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500 mL |
| ATC code | B05BB |
| ATC description | I.V. SOLUTIONS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-02-01 |
| Actual discontinuation date | 2022-08-04 |
| Remaining supply date | 2022-02-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-11-16 | French | Compare |
| v3 | 2022-11-16 | English | Compare |
| v2 | 2021-11-02 | French | Compare |
| v1 | 2021-11-02 | English | Compare |
Showing 1 to 4 of 4